221 related articles for article (PubMed ID: 9451505)
1. A useful method to evaluate bone resorption inhibitors, using osteoclast-like multinucleated cells.
Sugawara K; Hamada M; Hosoi S; Tamaoki T
Anal Biochem; 1998 Jan; 255(2):204-10. PubMed ID: 9451505
[TBL] [Abstract][Full Text] [Related]
2. S 12911-2 inhibits osteoclastic bone resorption in vitro.
Takahashi N; Sasaki T; Tsouderos Y; Suda T
J Bone Miner Res; 2003 Jun; 18(6):1082-7. PubMed ID: 12817762
[TBL] [Abstract][Full Text] [Related]
3. The regulation of pHi in osteoclasts is dependent on the culture substrate and on the stage of the resorption cycle.
Lehenkari PP; Laitala-Leinonen T; Linna TJ; Väänänen HK
Biochem Biophys Res Commun; 1997 Jun; 235(3):838-44. PubMed ID: 9207248
[TBL] [Abstract][Full Text] [Related]
4. Possible involvement of focal adhesion kinase, p125FAK, in osteoclastic bone resorption.
Tanaka S; Takahashi N; Udagawa N; Murakami H; Nakamura I; Kurokawa T; Suda T
J Cell Biochem; 1995 Aug; 58(4):424-35. PubMed ID: 7593264
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of osteoclast mediated bone resorption--rationale for the design of new therapeutics.
Väänänen K
Adv Drug Deliv Rev; 2005 May; 57(7):959-71. PubMed ID: 15876398
[TBL] [Abstract][Full Text] [Related]
6. Everolimus suppresses cancellous bone loss, bone resorption, and cathepsin K expression by osteoclasts.
Kneissel M; Luong-Nguyen NH; Baptist M; Cortesi R; Zumstein-Mecker S; Kossida S; O'Reilly T; Lane H; Susa M
Bone; 2004 Nov; 35(5):1144-56. PubMed ID: 15542040
[TBL] [Abstract][Full Text] [Related]
7. A vacuolar ATPase inhibitor, FR167356, prevents bone resorption in ovariectomized rats with high potency and specificity: potential for clinical application.
Niikura K; Takeshita N; Takano M
J Bone Miner Res; 2005 Sep; 20(9):1579-88. PubMed ID: 16059630
[TBL] [Abstract][Full Text] [Related]
8. Suramin suppresses hypercalcemia and osteoclastic bone resorption in nude mice bearing a human squamous cancer.
Yoneda T; Williams P; Rhine C; Boyce BF; Dunstan C; Mundy GR
Cancer Res; 1995 May; 55(9):1989-93. PubMed ID: 7728770
[TBL] [Abstract][Full Text] [Related]
9. Antithetic effects of ryanodine and ruthenium red on osteoclast-mediated bone resorption and intracellular calcium concentrations.
Ritchie CK; Strei TA; Maercklein PB; Fitzpatrick LA
J Cell Biochem; 1995 Oct; 59(2):281-9. PubMed ID: 8904321
[TBL] [Abstract][Full Text] [Related]
10. Effects of calcitonin gene-related peptide on bone resorption mediated by interleukin-1.
Zhang WZ; Yu SF; Zheng LF
Chin Med J (Engl); 1994 May; 107(5):351-4. PubMed ID: 7924575
[TBL] [Abstract][Full Text] [Related]
11. New resorption assay with mouse osteoclast-like multinucleated cells formed in vitro.
Tamura T; Takahashi N; Akatsu T; Sasaki T; Udagawa N; Tanaka S; Suda T
J Bone Miner Res; 1993 Aug; 8(8):953-60. PubMed ID: 7692706
[TBL] [Abstract][Full Text] [Related]
12. Quantitative and reliable in vitro method combining scanning electron microscopy and image analysis for the screening of osteotropic modulators.
Grimandi G; Soueidan A; Anjrini AA; Badran Z; Pilet P; Daculsi G; Faucheux C; Bouler JM; Guicheux J
Microsc Res Tech; 2006 Aug; 69(8):606-12. PubMed ID: 16718652
[TBL] [Abstract][Full Text] [Related]
13. A reappraisal of the effect of extracellular calcium on osteoclastic bone resorption.
Hall TJ
Biochem Biophys Res Commun; 1994 Jul; 202(1):456-62. PubMed ID: 8037747
[TBL] [Abstract][Full Text] [Related]
14. Protein tyrosine kinase inhibitors increase cytosolic calcium and inhibit actin organization as resorbing activity in rat osteoclasts.
Kajiya H; Okabe K; Okamoto F; Tsuzuki T; Soeda H
J Cell Physiol; 2000 Apr; 183(1):83-90. PubMed ID: 10699969
[TBL] [Abstract][Full Text] [Related]
15. Regulation of bone resorption and osteoclast survival by nitric oxide: possible involvement of NMDA-receptor.
Mentaverri R; Kamel S; Wattel A; Prouillet C; Sevenet N; Petit JP; Tordjmann T; Brazier M
J Cell Biochem; 2003 Apr; 88(6):1145-56. PubMed ID: 12647297
[TBL] [Abstract][Full Text] [Related]
16. Effects of electromagnetic stimulation on the functional responsiveness of isolated rat osteoclasts.
Shankar VS; Simon BJ; Bax CM; Pazianas M; Moonga BS; Adebanjo OA; Zaidi M
J Cell Physiol; 1998 Sep; 176(3):537-44. PubMed ID: 9699506
[TBL] [Abstract][Full Text] [Related]
17. Characterization of circulating human osteoclast progenitors: development of in vitro resorption assay.
Husheem M; Nyman JK; Vääräniemi J; Vaananen HK; Hentunen TA
Calcif Tissue Int; 2005 Mar; 76(3):222-30. PubMed ID: 15692727
[TBL] [Abstract][Full Text] [Related]
18. Triterpenoids from Cimicifugae rhizoma, a novel class of inhibitors on bone resorption and ovariectomy-induced bone loss.
Li JX; Liu J; He CC; Yu ZY; Du Y; Kadota S; Seto H
Maturitas; 2007 Sep; 58(1):59-69. PubMed ID: 17658706
[TBL] [Abstract][Full Text] [Related]
19. A comparison between the effects of hydrophobic and hydrophilic statins on osteoclast function in vitro and ovariectomy-induced bone loss in vivo.
Hughes A; Rogers MJ; Idris AI; Crockett JC
Calcif Tissue Int; 2007 Nov; 81(5):403-13. PubMed ID: 17982704
[TBL] [Abstract][Full Text] [Related]
20. The relationship between calcium accumulation in osteoclast mitochondrial granules and bone resorption.
Kawahara I; Koide M; Tadokoro O; Udagawa N; Nakamura H; Takahashi N; Ozawa H
Bone; 2009 Nov; 45(5):980-6. PubMed ID: 19631304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
